EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components

Liana Lantong Sumbu iD, Tonnii Loong-Loong Sia iD, Mong-How Ooi iD, Anand Mohan iD, Jin-Shyan Wong iD, Yuwana Podin iD

Pathogens · 2026

DOI: 10.3390/pathogens15010110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Liana Lantong Sumbu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Kota Samarahan 94300, Sarawak, Malaysia. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Trimethoprim, Sulfamethoxazole Drug Combination, Melioidosis, Anti-Bacterial Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Health and Community Medicine, Universiti Malaysia Sarawak.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Sarawak, Malaysian Borneo, where it is represented by a unique gentamicin-susceptible population. Despite trimethoprim-sulfamethoxazole (co-trimoxazole) being the cornerstone of eradication therapy, emerging reports of elevated minimum inhibitory concentrations (MICs) among Sarawak isolates have raised concerns over its clinical efficacy. We performed a retrospective and comprehensive antibiotic susceptibility assessment of clinical B. pseudomallei isolates from hospitals across Sarawak. Susceptibility to trimethoprim-sulfamethoxazole was determined using disk diffusion and the E-test, interpreted by both CLSI and EUCAST guidelines. Resistance to the individual components, trimethoprim and sulfamethoxazole, was characterized by broth microdilution. The results demonstrated a high prevalence of trimethoprim-sulfamethoxazole susceptibility, with 96.3% of isolates susceptible by CLSI criteria and 97.6% by EUCAST criteria. Interestingly, broth microdilution revealed that resistance to trimethoprim and sulfamethoxazole individually did not confer resistance to the synergistic combination. Our analysis validated CLSI guidelines as the most reliable standard for antimicrobial resistance surveillance in this region. This study provides evidence that trimethoprim-sulfamethoxazole remains effective for melioidosis treatment in Sarawak, offering crucial reassurance to clinicians. The paradoxical finding of susceptibility to the drug combination despite resistance to its individual components underscores the critical importance of the synergistic activity of trimethoprim-sulfamethoxazole and highlights the need for further investigation into the molecular basis of resistance in this distinct B. pseudomallei population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkholderia pseudomalleiTrimethoprim, Sulfamethoxazole Drug CombinationMelioidosisAnti-Bacterial AgentsDrug Resistance, BacterialMicrobial Sensitivity TestsHumansBorneoRetrospective StudiesMalaysia

Stichwörter der Autor:innen

Burkholderia pseudomalleiSarawakantibiotic susceptibilitygentamicin-susceptiblemelioidosistrimethoprim-sulfamethoxazole

Substanzen

Trimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial Agents

Autor:innen und Institutionen

  • Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Kota Samarahan 94300, Sarawak, Malaysia.
  • Department of Medicine, Miri Hospital, Miri 98000, Sarawak, Malaysia.
  • Department of Paediatrics, Sarawak General Hospital, Kuching 93586, Sarawak, Malaysia.
  • Department of Paediatrics, Bintulu Hospital, Bintulu 97000, Sarawak, Malaysia.
  • Department of Internal Medicine, Borneo Medical Centre, Kuching 93350, Sarawak, Malaysia.

ORCID-Profile: Liana Lantong Sumbu, Tonnii Loong-Loong Sia, Mong-How Ooi, Anand Mohan, Jin-Shyan Wong, Yuwana Podin

Förderung

  • Institute of Health and Community Medicine, Universiti Malaysia Sarawak

Zitieren

APA

Sumbu, L. L., Sia, T. L., Ooi, M. H., Mohan, A., Wong, J. S., & Podin, Y. (2026). Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components. Pathogens. https://doi.org/10.3390/pathogens15010110

Vancouver

Sumbu LL, Sia TL, Ooi MH, Mohan A, Wong JS, Podin Y. Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components. Pathogens. 2026. doi:10.3390/pathogens15010110

BibTeX
@article{Sumbu2026,
  author = {Sumbu, Liana Lantong and Sia, Tonnii Loong-Loong and Ooi, Mong-How and Mohan, Anand and Wong, Jin-Shyan and Podin, Yuwana},
  title = {Burkholderia pseudomallei in Sarawak, Malaysian Borneo, Remains Highly Susceptible to Trimethoprim-Sulfamethoxazole Despite Resistance to Its Individual Components},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15010110}
}
Kostenlos starten →